{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:41:32Z","timestamp":1789591292605,"version":"build-2803163510"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13063-017-2433-2","type":"journal-article","created":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T14:20:31Z","timestamp":1516285231000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["The benefits and tolerance of exercise in myasthenia gravis (MGEX): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"19","author":[{"name":"the MGEX Study Group","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Birnbaum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Hogrel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raphael","family":"Porcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Portero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Clair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Eymard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Demeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Bassez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcela","family":"Gargiulo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Lou\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Berrih-Aknin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa","family":"Jobic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Aegerter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Thoumie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarek","family":"Sharshar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,1,18]]},"reference":[{"key":"2433_CR1","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000279334","volume":"34","author":"A McGrogan","year":"2010","unstructured":"McGrogan A, Sneddon S, de Vries CS. The incidence of myasthenia gravis: a systematic literature review. Neuroepidemiology. 2010;34:171\u201383.","journal-title":"Neuroepidemiology."},{"key":"2433_CR2","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.jaut.2014.01.003","volume":"48\u201349","author":"S Berrih-Aknin","year":"2014","unstructured":"Berrih-Aknin S, Frenkian-Cuvelier M, Eymard B. Diagnostic and clinical classification of autoimmune myasthenia gravis. J Autoimmun. 2014;48\u201349:143\u20138.","journal-title":"J Autoimmun."},{"key":"2433_CR3","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1002\/mus.20950","volume":"37","author":"D Grob","year":"2008","unstructured":"Grob D, Brunner N, Namba T, Pagala M. Lifetime course of myasthenia gravis. Muscle Nerve. 2008;37:141\u20139.","journal-title":"Muscle Nerve."},{"key":"2433_CR4","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1007\/s100720100066","volume":"22","author":"L Padua","year":"2001","unstructured":"Padua L, Evoli A, Aprile I, Caliandro P, Mazza S, Padua R, et al. Health-related quality of life in patients with myasthenia gravis and the relationship between patient-oriented assessment and conventional measurements. Neurol Sci. 2001;22:363\u20139.","journal-title":"Neurol Sci."},{"key":"2433_CR5","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1002\/mus.1034","volume":"24","author":"RH Paul","year":"2001","unstructured":"Paul RH, Nash JM, Cohen RA, Gilchrist JM, Goldstein JM. Quality of life and well-being of patients with myasthenia gravis. Muscle Nerve. 2001;24:512\u20136.","journal-title":"Muscle Nerve."},{"key":"2433_CR6","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1186\/1477-7525-8-129","volume":"8","author":"S Twork","year":"2010","unstructured":"Twork S, Wiesmeth S, Klewer J, Pohlau D, Kugler J. Quality of life and life circumstances in German myasthenia gravis patients. Health Qual Life Outcomes. 2010;8:129.","journal-title":"Health Qual Life Outcomes."},{"key":"2433_CR7","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1097\/01376517-199806000-00007","volume":"30","author":"ME Grohar-Murray","year":"1998","unstructured":"Grohar-Murray ME, Becker A, Reilly S, Ricci M. Self-care actions to manage fatigue among myasthenia gravis patients. J Neurosci Nurs. 1998;30:191\u20139.","journal-title":"J Neurosci Nurs."},{"key":"2433_CR8","doi-asserted-by":"publisher","first-page":"i3857","DOI":"10.1136\/bmj.i3857","volume":"354","author":"HH Kyu","year":"2016","unstructured":"Kyu HH, Bachman VF, Alexander LT, Mumford JE, Afshin A, Estep K, et al. Physical activity and risk of breast cancer, colon cancer, diabetes, ischemic heart disease, and ischemic stroke events: systematic review and dose-response meta-analysis for the Global Burden of Disease Study 2013. BMJ. 2016;354:i3857.","journal-title":"BMJ."},{"key":"2433_CR9","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1136\/bjsports-2016-096343","volume":"51","author":"RJ Thomas","year":"2017","unstructured":"Thomas RJ, Kenfield SA, Jimenez A. Exercise-induced biochemical changes and their potential influence on cancer: a scientific review. Br J Sports Med. 2017;51:640\u20134.","journal-title":"Br J Sports Med"},{"key":"2433_CR10","doi-asserted-by":"publisher","first-page":"718789","DOI":"10.5402\/2012\/718789","volume":"2012","author":"P Kokkinos","year":"2012","unstructured":"Kokkinos P. Physical activity, health benefits, and mortality risk. ISRN Cardiol. 2012;2012:718789.","journal-title":"ISRN Cardiol."},{"key":"2433_CR11","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1177\/1352458507080464","volume":"14","author":"RW Motl","year":"2008","unstructured":"Motl RW, Gosney JL. Effect of exercise training on quality of life in multiple sclerosis: a meta-analysis. Mult Scler. 2008;14:129\u201335.","journal-title":"Mult Scler."},{"key":"2433_CR12","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/j.apmr.2015.01.005","volume":"96","author":"BC Adamson","year":"2015","unstructured":"Adamson BC, Ensari I, Motl RW. Effect of exercise on depressive symptoms in adults with neurologic disorders: a systematic review and meta-analysis. Arch Phys Med Rehabil. 2015;96:1329\u201338.","journal-title":"Arch Phys Med Rehabil."},{"key":"2433_CR13","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1212\/01.wnl.0000264418.92308.a4","volume":"68","author":"VD Bello-Haas","year":"2007","unstructured":"Bello-Haas VD, Florence JM, Kloos AD, Scheirbecker J, Lopate G, Hayes SM, et al. A randomized controlled trial of resistance exercise in individuals with ALS. Neurology. 2007;68:2003\u20137.","journal-title":"Neurology."},{"key":"2433_CR14","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1136\/bjsports-2015-f5577rep","volume":"49","author":"H Naci","year":"2015","unstructured":"Naci H, Ioannidis JP. Comparative effectiveness of exercise and drug interventions on mortality outcomes: metaepidemiological study. Br J Sports Med. 2015;49:1414\u201322.","journal-title":"Br J Sports Med."},{"key":"2433_CR15","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1055\/s-0034-1396008","volume":"34","author":"Y Anziska","year":"2014","unstructured":"Anziska Y, Inan S. Exercise in neuromuscular disease. Semin Neurol. 2014;34:542\u201356.","journal-title":"Semin Neurol."},{"key":"2433_CR16","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.apmr.2007.07.024","volume":"88","author":"EH Cup","year":"2007","unstructured":"Cup EH, Pieterse AJ, Ten Broek-Pastoor JM, Munneke M, van Engelen BG, Hendricks HT, et al. Exercise therapy and other types of physical therapy for patients with neuromuscular diseases: a systematic review. Arch Phys Med Rehabil. 2007;88:1452\u201364.","journal-title":"Arch Phys Med Rehabil."},{"key":"2433_CR17","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1097\/00005768-200106000-00003","volume":"33","author":"JR Stout","year":"2001","unstructured":"Stout JR, Eckerson JM, May E, Coulter C, Bradley-Popovich GE. Effects of resistance exercise and creatine supplementation on myasthenia gravis: a case study. Med Sci Sports Exerc. 2001;33:869\u201372.","journal-title":"Med Sci Sports Exerc."},{"key":"2433_CR18","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1097\/PHM.0b013e31824663c6","volume":"91","author":"BV Scheer","year":"2012","unstructured":"Scheer BV, Valero-Burgos E, Costa R. Myasthenia gravis and endurance exercise. Am J Phys Med Rehabil. 2012;91:725\u20137.","journal-title":"Am J Phys Med Rehabil."},{"key":"2433_CR19","doi-asserted-by":"publisher","first-page":"1975","DOI":"10.1097\/00005768-200012000-00001","volume":"32","author":"JJ Leddy","year":"2000","unstructured":"Leddy JJ, Chutkow JG. Myasthenia gravis in a collegiate football player. Med Sci Sports Exerc. 2000;32:1975\u20139.","journal-title":"Med Sci Sports Exerc."},{"issue":"1","key":"2433_CR20","first-page":"13","volume":"33","author":"L Davidson","year":"2005","unstructured":"Davidson L, Hale LA. Exercise prescription in the physiotherapeutic management of Myasthenia Gravis: a case report. New Zealand Journal of Physiotherapy. 2005;33(1):13\u20138.","journal-title":"New Zealand Journal of Physiotherapy"},{"key":"2433_CR21","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/S0003-9993(23)00011-4","volume":"74","author":"EL Lohi","year":"1993","unstructured":"Lohi EL, Lindberg C, Andersen O. Physical training effects in myasthenia gravis. Arch Phys Med Rehabil. 1993;74:1178\u201380.","journal-title":"Arch Phys Med Rehabil."},{"key":"2433_CR22","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.25552","volume":"56","author":"MA Rahbek","year":"2017","unstructured":"Rahbek MA, Mikkelsen EE, Overgaard K, Vinge L, Andersen H, Dalgas U. Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle Nerve. 2017;56:700\u20139.","journal-title":"Muscle Nerve."},{"key":"2433_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1002\/mus.25493","volume":"56","author":"E Westerberg","year":"2017","unstructured":"Westerberg E, Molin CJ, Lindblad I, Emtner M, Punga AR. Physical exercise in myasthenia gravis is safe and improves neuromuscular parameters and physical performance-based measures: A pilot study. Muscle Nerve. 2017;56:207\u201314.","journal-title":"Muscle Nerve."},{"key":"2433_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3325\/cmj.2009.50.105","volume":"50","author":"K Krleza-Jeric","year":"2009","unstructured":"Krleza-Jeric K, Lemmens T. 7th revision of the Declaration of Helsinki: good news for the transparency of clinical trials. Croat Med J. 2009;50:105\u201310.","journal-title":"Croat Med J."},{"key":"2433_CR25","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.ijsu.2011.10.001","volume":"10","author":"D Moher","year":"2012","unstructured":"Moher D, Hopewell S, Schulz KF, Montori V, Gotzsche PC, Devereaux PJ, et al. CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. Int J Surg. 2012;10:28\u201355.","journal-title":"Int J Surg."},{"key":"2433_CR26","doi-asserted-by":"publisher","first-page":"295","DOI":"10.7326\/0003-4819-148-4-200802190-00008","volume":"148","author":"I Boutron","year":"2008","unstructured":"Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med. 2008;148:295\u2013309.","journal-title":"Ann Intern Med."},{"key":"2433_CR27","doi-asserted-by":"publisher","first-page":"e7586","DOI":"10.1136\/bmj.e7586","volume":"346","author":"AW Chan","year":"2013","unstructured":"Chan AW, Tetzlaff JM, Gotzsche PC, Altman DG, Mann H, Berlin JA, et al. SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials. BMJ. 2013;346:e7586.","journal-title":"BMJ."},{"key":"2433_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/mus.21883","volume":"43","author":"TM Burns","year":"2011","unstructured":"Burns TM, Grouse CK, Wolfe GI, Conaway MR, Sanders DB, MG Composite and MG-OL15 Study Group. The MG-QOL15 for following the health-related quality of life of patients with myasthenia gravis. Muscle Nerve. 2011;43:14\u20138.","journal-title":"Muscle Nerve"},{"key":"2433_CR29","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.55.1.16","volume":"55","author":"A Jaretzki 3rd","year":"2000","unstructured":"Jaretzki 3rd A, Barohn RJ, Ernstoff RM, Kaminski HJ, Keesey JC, Penn AS, et al. Myasthenia gravis: recommendations for clinical research standards. Task Force of the Medical Scientific Advisory Board of the Myasthenia Gravis Foundation of America. Neurology. 2000;55:16\u201323.","journal-title":"Neurology."},{"key":"2433_CR30","doi-asserted-by":"publisher","first-page":"1514","DOI":"10.2522\/ptj.20150668","volume":"96","author":"SC Slade","year":"2016","unstructured":"Slade SC, Dionne CE, Underwood M, Buchbinder R, Beck B, Bennell K, et al. Consensus on Exercise Reporting Template (CERT): Modified Delphi Study. Phys Ther. 2016;96:1514\u201324.","journal-title":"Phys Ther."},{"key":"2433_CR31","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1002\/mus.25381","volume":"55","author":"S Birnbaum","year":"2017","unstructured":"Birnbaum S, Ghout I, Demeret S, Bolgert F, Eymard B, Sharshar T, et al. Translation, cross-cultural adaptation, and validation of the French version of the Myasthenia Gravis Quality of Life Scale (MG-QOL 15). Muscle Nerve. 2017;55:639\u201345.","journal-title":"Muscle Nerve."},{"key":"2433_CR32","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1196\/annals.1254.058","volume":"998","author":"P Gajdos","year":"2003","unstructured":"Gajdos P, Sharshar T, Chevret S. Standards of measurements in myasthenia gravis. Ann N Y Acad Sci. 2003;998:445\u201352.","journal-title":"Ann N Y Acad Sci."},{"key":"2433_CR33","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1007\/s004150050585","volume":"247","author":"T Sharshar","year":"2000","unstructured":"Sharshar T, Chevret S, Mazighi M, Chillet P, Huberfeld G, Berreotta C, et al. Validity and reliability of two muscle strength scores commonly used as endpoints in assessing treatment of myasthenia gravis. J Neurol. 2000;247:286\u201390.","journal-title":"J Neurol."},{"key":"2433_CR34","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ. Myasthenia gravis activities of daily living profile. Neurology. 1999;52:1487\u20139.","journal-title":"Neurology."},{"key":"2433_CR35","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1183\/09031936.05.00034805","volume":"26","author":"MR Miller","year":"2005","unstructured":"Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, et al. Standardisation of spirometry. Eur Respir J. 2005;26:319\u201338.","journal-title":"Eur Respir J."},{"key":"2433_CR36","doi-asserted-by":"crossref","unstructured":"American Thoracic Society\/European Respiratory Society. ATS\/ERS Joint statement on respiratory muscle testing. Am J Respir Crit Care Med. 2002;166:518\u201324.","DOI":"10.1164\/rccm.166.4.518"},{"key":"2433_CR37","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.clinph.2007.09.126","volume":"119","author":"MJ Zwarts","year":"2008","unstructured":"Zwarts MJ, Bleijenberg G, van Engelen BG. Clinical neurophysiology of fatigue. Clin Neurophysiol. 2008;119:2\u201310.","journal-title":"Clin Neurophysiol."},{"key":"2433_CR38","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1002\/0471678384","volume-title":"Electromyography physiology, engineering, and noninvasive applications","author":"R Merletti","year":"2004","unstructured":"Merletti R, Rainoldi A, Farina D. Myoelectric manifestations of muscle fatigue. In: Merletti R, Parker PA, editors. Electromyography physiology, engineering, and noninvasive applications. NJ: John Wiley & Sons; 2004. p. 233\u201358."},{"key":"2433_CR39","unstructured":"Hermens HJ, Freriks B, Merletti R, Stegeman D, Blok J, Rau G, et al. European recommendations for surface electromyography SENIAM 8. Roessingh research and development b.v ISBN 90-75452-15-2; 1999."},{"key":"2433_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12891-015-0612-4","volume":"16","author":"JY Hogrel","year":"2015","unstructured":"Hogrel JY. Grip strength measured by high precision dynamometry in healthy subjects from 5 to 80\u00a0years. BMC Musculoskelet Disord. 2015;16:139.","journal-title":"BMC Musculoskelet Disord."},{"key":"2433_CR41","first-page":"783","volume":"48","author":"PL Enright","year":"2003","unstructured":"Enright PL. The six-minute walk test. Respir Care. 2003;48:783\u20135.","journal-title":"Respir Care."},{"key":"2433_CR42","doi-asserted-by":"crossref","unstructured":"American Thoracic Society. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166:111\u201317.","DOI":"10.1164\/ajrccm.166.1.at1102"},{"key":"2433_CR43","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1249\/MSS.0b013e31818ff636","volume":"41","author":"VT Hees Van","year":"2009","unstructured":"Van Hees VT, Slootmaker SM, De Groot G, Van Mechelen W, Van Lummel RC. Reproducibility of a triaxial seismic accelerometer (DynaPort). Med Sci Sports Exerc. 2009;41:810\u20137.","journal-title":"Med Sci Sports Exerc."},{"key":"2433_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1093\/ajcn\/37.3.461","volume":"37","author":"C Bouchard","year":"1983","unstructured":"Bouchard C, Tremblay A, Leblanc C, Lortie G, Savard R, Theriault G. A method to assess energy expenditure in children and adults. Am J Clin Nutr. 1983;37:461\u20137.","journal-title":"Am J Clin Nutr."},{"key":"2433_CR45","doi-asserted-by":"crossref","unstructured":"Hodges WF, Spielberger CD. Digit span: an indicant of trait or state anxiety? J Consult Clin Psychol. 1969;33:430\u20134.","DOI":"10.1037\/h0027813"},{"key":"2433_CR46","volume-title":"Le manuel du STAI-Y de CD Spielberger, adaptation fran\u00e7aise","author":"M Bruchon-Schweitzer","year":"1993","unstructured":"Bruchon-Schweitzer M, Paulhan I. Le manuel du STAI-Y de CD Spielberger, adaptation fran\u00e7aise. Paris: ECPA; 1993."},{"key":"2433_CR47","volume-title":"Inventaire d\u2019estime de soi","author":"S Coopersmith","year":"1984","unstructured":"Coopersmith S. Inventaire d\u2019estime de soi. Paris: Edition du Centre de Psychologie Appliqu\u00e9e; 1984."},{"key":"2433_CR48","first-page":"77","volume":"12","author":"L Collet","year":"1986","unstructured":"Collet L, Cottraux J. [The shortened Beck depression inventory (13 items). Study of the concurrent validity with the Hamilton scale and Widlocher's retardation scale]. Encephale. 1986;12:77\u20139.","journal-title":"Encephale"},{"key":"2433_CR49","first-page":"22","volume":"59 Suppl 20","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59 Suppl 20:22\u201333. quiz 34\u201357.","journal-title":"J Clin Psychiatry"},{"key":"2433_CR50","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","volume":"13","author":"SM Skevington","year":"2004","unstructured":"Skevington SM, Lotfy M, O\u2019Connell KA. The World Health Organization\u2019s WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group. Qual Life Res. 2004;13:299\u2013310.","journal-title":"Qual Life Res"},{"key":"2433_CR51","first-page":"13","volume":"XXVI","author":"A Leplege","year":"2000","unstructured":"Leplege A, Reveillere C, Ecosse E, Caria A, Riviere H. Propri\u00e9t\u00e9s psychom\u00e9triques d'un nouvel instrument d\u2019\u00e9valuation de la qualit\u00e9 de vie, le WHO-QOL-26, \u00e0 partir d\u2019une population de malades neuro-musculaires. L\u2019Encephale. 2000;XXVI:13\u201322.","journal-title":"L\u2019Encephale"},{"key":"2433_CR52","volume-title":"Guide d\u2019introduction au logiciel QSR NVivo 7. Les Cahiers P\u00e9dagogiques","author":"F Deschenaux","year":"2007","unstructured":"Deschenaux F. Guide d\u2019introduction au logiciel QSR NVivo 7. Les Cahiers P\u00e9dagogiques. Trois Rivi\u00e8res, Qu\u00e9bec (CA): Association pour la recherche Qualitative; 2007."},{"key":"2433_CR53","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.evopsy.2003.10.002","volume":"69","author":"C Morin","year":"2004","unstructured":"Morin C, Thibierge S. L\u2019image du corps en neurologie: de la c\u00e9nesth\u00e9sie \u00e0 l\u2019image sp\u00e9culaire. Apports cliniques et th\u00e9oriques de la psychanalyse. L\u2019Evolution psychiatrique. 2004;69:417\u201330.","journal-title":"L\u2019Evolution psychiatrique"},{"key":"2433_CR54","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1189\/jlb.0408244","volume":"84","author":"KL Timmerman","year":"2008","unstructured":"Timmerman KL, Flynn MG, Coen PM, Markofski MM, Pence BD. Exercise training-induced lowering of inflammatory (CD14\u2009+\u2009CD16+) monocytes: a role in the anti-inflammatory influence of exercise? J Leukoc Biol. 2008;84:1271\u20138.","journal-title":"J Leukoc Biol."}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13063-017-2433-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T16:03:07Z","timestamp":1693497787000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/s13063-017-2433-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,18]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["2433"],"URL":"https:\/\/doi.org\/10.1186\/s13063-017-2433-2","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,18]]},"assertion":[{"value":"28 February 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 December 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Authors' information"}},{"value":"Ethics approval for all participating centres has been provided by an ethics committee,Comit\u00e9 de Protection des Personnes Ile de France XI, in accordance with French regulations under the number #13064 on 13 December 2013 and authorised by theAgence National de S\u00e9curit\u00e9 du M\u00e9dicament et des produits de sant\u00e9, reference 131300B-32, on 11 October 2013. All patients are required to provide written informed consent before inclusion in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"49"}}